By

Cellceutix Corporation , a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, has announced the completion of enrollment in...

By

The U.S. Food and Drug Administration is advising consumers to be aware of products sold online claiming to prevent or treat the Ebola virus. Since the outbreak of the Ebola virus in West Africa, the FDA...

By

The Drugs for Neglected Diseases initiative (DNDi) announced Tuesday at the International Congress of Parasitology (ICOPA), the launch of a Phase II drug trial to test fexinidazole, a drug shelved in the...

By

PRESS RELEASE Today, at the Wurtsboro Open Ridge Space in Bloomingburg, U.S. Senator Charles E. Schumer urged the federal Food and Drug Administration (FDA) to investigate and proactively address a potential...

By

Cubist Pharmaceuticals, Inc. Wednesday announced it is voluntarily recalling certain lots of CUBICIN® (daptomycin for injection) to the user level due to the potential presence of glass particulate matter...

The Food and Drug Administration (FDA) has verbally confirmed they have modified the full clinical hold placed on Tekmira Pharmaceutical’s TKM-Ebola Investigational New Drug Application (IND) to...

By

The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Orbactiv is approved to treat patients with acute bacterial skin...

By

Drug-resistant malaria parasites have spread to critical border regions of South-east Asia, seriously threatening global malaria control and elimination programmes, according to a study published in the...

By

Basilea Pharmaceutica Ltd. reported this week that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the oral and intravenous treatment...

By

CORVALLIS, Ore. – New research suggests that use of antibiotics is still prevalent among terminal patients who have chosen hospice care as an end-of-life option, despite little evidence that the medications...